EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-6.19%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.09B
AUM Growth
+$1.09B
(-9.9%)
Cap. Flow
-$52.6M
Cap. Flow
% of AUM
-4.84%
Top 10 Holdings %
Top 10 Hldgs %
50.97%
Holding
109
New
9
Increased
26
Reduced
34
Closed
23
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$39.1M |
| 2 |
GSK
GSK
|
$30.5M |
| 3 |
Masimo
MASI
|
$30.4M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$17.3M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$16.8M |
Top Sells
| 1 |
McKesson
MCK
|
$25.7M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$23.5M |
| 3 |
United Therapeutics
UTHR
|
$17.9M |
| 4 |
Envista
NVST
|
$13.6M |
| 5 |
AstraZeneca
AZN
|
$13.5M |
Sector Composition
| 1 | Healthcare | 94.41% |
| 2 | Industrials | 3.35% |
| 3 | Technology | 0% |
